Resource

Letter to FDA re: Phenibut

ShareThis

This letter to the FDA from CSPI and the Alabama Association of Christian Recovery Ministries (ACCRM) urges the agency to issue warning letters and pursue enforcement action against dietary supplement companies that illegally market phenibut products.

Appendix A: Phenibut products marketed as supplements